Market Research Logo

Burzynski Research Institute, Inc. (BZYR) - Strategic SWOT Analysis Review

Burzynski Research Institute, Inc. (BZYR) - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Burzynski Research Institute, Inc. (BRI) is a research based biopharmaceutical company. It carries out the identification, production, marketing, and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids. The company offers these compounds under the trade name Antineoplastons. BRI's product portfolio consists of Antineoplastons, namely, A10 and AS2-1, being evaluated in Phase II clinical trial for the treatment of cancer. It also examines pharmacokinetics and pharmacodynamics of Antineoplastons in patients with neoplastic disease, and offers consulting services. The company has a research facility in Stafford, Texas. BRI is headquartered in Houston, Texas, the US.

Burzynski Research Institute, Inc. Key Recent Developments

Oct 26, 2015: Burzynski Research Institute Announces Publications Documenting Long-term Survival in Malignant Brain Tumors Following Antineoplaston Therapy
Mar 26, 2015: Burzynski Research Institute Announces Publication of Phase 2 Clinical Study in Metastatic Colon Adenocarcinoma of the Liver

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Burzynski Research Institute, Inc. - Key Facts
Burzynski Research Institute, Inc. - Key Employees
Burzynski Research Institute, Inc. - Key Employee Biographies
Burzynski Research Institute, Inc. - Major Products and Services
Burzynski Research Institute, Inc. - Pharmaceutical Pipeline Products Data
Burzynski Research Institute, Inc., Pipeline Products by Therapy Area
Burzynski Research Institute, Inc., Pipeline Products by Development Phase
Burzynski Research Institute, Inc. - History
Burzynski Research Institute, Inc. - Company Statement
Burzynski Research Institute, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Burzynski Research Institute, Inc. - Business Description
Burzynski Research Institute, Inc. - SWOT Analysis
SWOT Analysis - Overview
Burzynski Research Institute, Inc. - Strengths
Burzynski Research Institute, Inc. - Weaknesses
Burzynski Research Institute, Inc. - Opportunities
Burzynski Research Institute, Inc. - Threats
Burzynski Research Institute, Inc. - Key Competitors
Section 3 – Company’s Recent Developments
Oct 26, 2015: Burzynski Research Institute Announces Publications Documenting Long-term Survival in Malignant Brain Tumors Following Antineoplaston Therapy
Mar 26, 2015: Burzynski Research Institute Announces Publication of Phase 2 Clinical Study in Metastatic Colon Adenocarcinoma of the Liver
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Burzynski Research Institute, Inc., Key Facts
Burzynski Research Institute, Inc., Key Employees
Burzynski Research Institute, Inc., Key Employee Biographies
Burzynski Research Institute, Inc., Major Products and Services
Burzynski Research Institute, Inc., Number of Pipeline Products by Therapy Area
Burzynski Research Institute, Inc., Number of Pipeline Products by Development Stage
Burzynski Research Institute, Inc., Pipeline Products By Therapy Area and Development Phase
Burzynski Research Institute, Inc., History
Burzynski Research Institute, Inc., Other Locations
Burzynski Research Institute, Inc., Key Competitors

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report